FDA Inspection 954263 — Rohit Dhall
The FDA completed an inspection of Rohit Dhall on Jan 5, 2016 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 5, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Phoenix, AZ (United States)
Additional Details
Clinical Investigator (CI)